(Q86591991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-β-dependent manner (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Nathella Pavan Kumar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kadar Moideen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Parakkal Jovvian George

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Chandrakumar Dolla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Paul Kumaran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Subash Babu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

19 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

390-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

Tuberculosis and diabetes mellitus: convergence of two epidemics

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

The impact of diabetes on tuberculosis treatment outcomes: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Type 2 diabetes and multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Cell-mediated immune responses in tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

The immune response in tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Th2 cytokines in susceptibility to tuberculosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

IL-17 and Th17 cells in tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Polyfunctional T cells in human tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Immune dysfunction in patients with diabetes mellitus (DM).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

State of the union between metabolism and the immune system in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Type 2 cytokines: mechanisms and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Regulatory T cells depress immune responses to protective antigens in active tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Immunoregulation in TB: observations and implications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545973

7 January 2021

Identifiers

DOI

10.1002/EJI.201545973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26518995%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference